| MeSH term | MeSH ID | Detail |
|---|---|---|
| Scleroderma, Limited | D045745 | 1 associated lipids |
| Arthropathy, Neurogenic | D001177 | 1 associated lipids |
| Foot Deformities, Acquired | D005531 | 2 associated lipids |
| Foot Injuries | D018409 | 1 associated lipids |
| Angioid Streaks | D000793 | 1 associated lipids |
| Adrenocortical Adenoma | D018246 | 1 associated lipids |
| POEMS Syndrome | D016878 | 1 associated lipids |
| Bone Diseases, Developmental | D001848 | 2 associated lipids |
| Rheumatic Fever | D012213 | 1 associated lipids |
| Progeria | D011371 | 3 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Gautam J et al. | An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. | 2016 | J. Pharm. Pharmacol. | pmid:27265669 |
| Owen S et al. | Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. | 2016 | Int. J. Oncol. | pmid:26781475 |
| Maser RE et al. | Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. | 2016 | J. Diabetes Complicat. | pmid:26775555 |
| Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
| Wang HL et al. | Protein biomarkers and microbial profiles in peri-implantitis. | 2016 | Clin Oral Implants Res | pmid:26424287 |
| Liu FQ et al. | Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. | 2016 | Circ. J. | pmid:27867157 |
| Kim CS et al. | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. | 2016 | PLoS ONE | pmid:27855207 |
| He M et al. | Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. | 2016 | Mol Med Rep | pmid:27277157 |
| Ye C et al. | [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27266195 |
| Bernardi S et al. | Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. | 2016 | Biomed Res Int | pmid:27200369 |